Señales en vivo de 215600.KQ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 02:30):

Stats
Volumen de hoy	521 393
Volumen promedio	1.08M
Capitalización de mercado	467.70B
EPS	KRW0 ( 2024-03-20 )
Próxima fecha de ganancias	( KRW0 ) 2024-05-12
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW5.88 (0.13%)

Volumen Correlación

Largo: -0.17 (neutral)

Corto: -0.62 (weak negative)

Signal:(56.326) Neutral

SillaJen, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

SillaJen, Inc. Correlación - Moneda/Commodity

0.44
( neutral )

0.49
( neutral )

0.22
( neutral )

-0.03
( neutral )

-0.29
( neutral )

-0.44
( neutral )

SillaJen, Inc. Finanzas

Annual	2023
Ingresos:	KRW3.94B
Beneficio Bruto:	KRW-16.36B (-415.27 %)
EPS:	KRW-198.16

FY	2023
Ingresos:	KRW3.94B
Beneficio Bruto:	KRW-16.36B (-415.27 %)
EPS:	KRW-198.16

FY	2022
Ingresos:	KRW5.01B
Beneficio Bruto:	KRW-18.77B (-374.33 %)
EPS:	KRW-239.25

Financial Reports:

No articles found.

SillaJen, Inc.

SillaJen, Inc. engages in the development and commercialization of oncolytic immunotherapy products. The company's lead product is Pexa-Vec, which is in Phase II clinical trial for the treatment of advanced liver cancer. It also develops JX-970 for the treatment of tumor tissues; and JX-900 is a series of modified vaccinia vaccine. The company was founded in 2006 and is headquartered in Seoul, South Korea.